|
• 介绍 • 一览表 • 症状 • 治疗
• 饮食习惯的改变 • 生活方式的改变 • 营养补充剂
• 草药 • 整体疗法 • 参考资料
闭经是指妇女没有月经周期。
闭经分为原发和继发,前者是指女性在16岁时仍未有初潮;后者是指原本有正常月经周期的妇女出现不正常的闭经[1]。对于闭经的妇女,其女性的性激素水平不足以刺激月经形成。这种情况有时与营养不良联系,例如神经性厌食症,或运动过度导致机体对营养和其它供应有更高需求[2,3]。关于闭经与压力的关系也已被阐明[4]。闭经也可能是卵巢,下丘脑或垂体的潜在严重病变所引起;因此,医师应该仔细分析长期慢性的闭经。长期的闭经可以导致骨质的提前丢失,并增加骨质疏松的几率[5]。在生理条件下,哺乳期妇女是没有月经的[6],但在此种情况下,没有骨质丢失的危险[7]。
闭经的辅助疗法
|
分类
|
营养补充剂
|
草药
|
|
首选
|
孕激素
|
|
|
次选
|
乙酰左旋肉碱
钙和维生素D 防止骨质丢失
维生素 B6
维生素 C
锌
|
蓝籽类叶牡丹
益母草
越桔
芸香
圣洁莓Vitex (agnus-castus)
西洋蓍草
|
|
首选 有可靠和相对一致的科研数据证明其对健康有显著改善。
次选 各有关科研结果相互矛盾、证据不充分或仅能初步表明其可改善健康状况或效果甚微。
其它 对草药来说,仅有传统用法可支持其应用,但尚无或仅有少量科学证据可证明其疗效。对营养补充剂来说,无科学证据支持和/或效果甚微。
|
闭经的症状
闭经的妇女可能有的症状包括月经周期的缺乏,面部毛发增多,阴毛、腋毛减少,音调低沉,乳房变小及乳头异常分泌物。
医药治疗
治疗闭经的处方药包括避孕药(Ortho Novum®, Loestrin®, Mircette®, Triphasil®),氯底酚胺(Clomiphene) (Clomid®, Serophene®);或促性腺激素释放激素(GnRH)治疗法,包括纳法雷林(Synarel®) 和安希雷林(andhistrelin)(Supprelin®)。
可能有益的饮食习惯
人们早已知道,极端的限制饮食可以导致闭经[8,9]。当这种限制来自进食紊乱,例如厌食和易饿病[10],专业的治疗就很必要。闭经的女性运动员可能是由于卡路里和其它营养成分摄入不足,有研究表明,当给她们的食谱上添加含有卡路里,蛋白质,糖类,脂肪,维生素,矿物质的营养饮料时,她们可以恢复月经[11,12]。然而,实验中,这些女运动员也降低了她们的运动量,这也可能对她们恢复月经周期有益处。
若和月经周期正常的妇女比较,月经次数少或闭经的妇女的食物中常常会有脂肪(尤其是饱和脂肪酸),蛋白,总卡路里较低的问题;此外她们的食谱中糖类和纤维素的比例较高[13,14,15]。在针对没有显著进食障碍的正常体重的妇女的初步研究中,可以用“接近正常,但缺乏脂肪”来形容有着闭经的妇女的食谱。这些妇女体内脂肪含量也相对较少[16,17]。在一项研究中,当妇女增加脂肪摄入量4个月后,她们的月经周期恢复正常,体内脂肪含量也回复正常[18]。
某些特殊的饮食习惯可能增加闭经发生的几率。一项初步研究发现,严格的生食习惯与体重下降和闭经联系紧密[19]。也有研究关注于素食主义者患闭经的易感性,但截至目前的研究结果还很不一致[20]。素食中可能富含一些被称为胡萝卜素的抗氧化剂。血液中有着较高胡萝卜素水平的妇女,较之于正常妇女,表现为更易出现闭经[21,22];而且,尽管研究没有发现高胡萝卜素水平直接与闭经相关,但却可能是一个起作用的因素[23]。在一项初步研究中,有着高胡萝卜素水平的闭经的素食主义妇女,在减少了其食物中的胡萝卜素摄入量后,其血液中的胡萝卜素水平下降,闭经的情况也得到改善[24]。女性素食主义者常常主要依靠豆制品作为其蛋白质的来源,很多实验表明,豆类食物的过多摄入会降低绝经期前妇女的雌激素和孕激素水平[25,26,27,28,29,30],尽管仍有一些实验没有得到类似结论[31,32]。在这些实验中,月经周期的改变并不一致,且没有一个实验发现高豆类饮食与闭经的联系。唯一的良好质控的对比实验发现:对于健康的,体重稳定的素食主义妇女,她们闭经的几率并不高于健康的,体重稳定的非素食主义妇女[33]。这项研究的作者推测:综合所有的证据和资料,素食习惯可能并不与闭经有联系。
可能有益的生活习惯
适量运动
对于绝经期前的妇女,适量运动对于整体健康有很多好处;但过量或剧烈运动可能导致闭经病增加提前骨质丢失的危险性,因为这对于整体的激素平衡不利[34]。一般说来,运动可以增加骨骼密度,但对于有着闭经的舞蹈者的研究发现,在持续两年的研究中[35],她们的骨密度都低于正常值。如何解释女性演员和运动员闭经的现象,可能和她们当中高比例的进食障碍有关。再加上她们经常运动,有着更高的体力和营养要求,于是可能导致她们的营养缺乏和机体脂肪比例下降,进而导致闭经和骨质丢失[36,37,38]。跑步和芭蕾舞是与闭经联系最为紧密地运动[39],有66%的女长跑运动员和芭蕾舞演员经历过闭经[40]。而对女性健美运动员的研究发现,81%经历过闭经,且很多有着营养缺乏的饮食习惯[41]。研究表明,当每周给以一天休息并每天服用含有添加卡路里,蛋白质,糖类,脂肪,维生素和矿物质的饮料的情况下[42,43],一些闭经的女运动员恢复了月经周期。但此项研究没有设置对照。
哺乳期激素水平变化
在健康女性中,哺乳期的激素水平变化同样可以导致闭经[44]。这种月经周期的变化,被称为哺乳期或产后闭经,与很多因素有关,包括产妇的营养健康状况。在发展中国家,当产妇的营养状况较差时,哺乳期闭经的时间可能较长[45,46,47,48],同样的情况在英国的卫生护理较差的女性中也可发现[49]。在美国,对于有着很好产后营养和护理的产妇的研究发现,较好的产妇营养状况,与较短的哺乳期闭经时间相关[50]。根据一项初步研究,当给予营养不良的产妇食物添加剂,无经期的长度可以缩短[51]。然而,一项对照实验[52]发现,在营养和护理条件较好的产妇,给予脱脂乳的食物补充,并不能减少无经期的长度。尽管延长的哺乳期闭经可以防止再次怀孕,但却并没有发现导致不可逆的骨质丢失[53]。
过度压力
过度的压力可以导致机体产生更多的肾上腺皮质激素考的松,有些研究发现高水平的考的松,与低水平的性激素联系,并可能导致闭经[54,55,56]。一项研究发现:相对于有正常月经周期的妇女,闭经的妇女对于压力有更高的考的松反应[57]。还没有研究来评估采用减小压力来治疗闭经的可行性。
戒烟
吸烟可能导致闭经。一项调查[58]显示,每天吸一包烟或更多的青年女性,更有可能闭经。然而,戒烟是否会使闭经妇女的月经周期正常化,仍然未知。
可能有益的营养补充剂
孕激素
已经至少有一项双盲实验表明[59]:口服型孕激素粉(每天200-300毫克)成功的使继发性闭经的妇女恢复月经。需要注意的是,激素治疗一定要在医生的指导下进行。
钙、维生素D
一项初步研究表明:尽管一年中每天补充1200毫克的钙和400国际单位的维生素D,闭经的女运动员仍然出现了骨质丢失的现象[60]。在一项对于闭经女护士(她们曾经历短暂的骨质丢失,但当月经正常时,不再丢失)的对照研究中,采用维生素复合制剂(400国际单位的维生素D和500毫克的钙)或安慰剂,每天两次。研究发现处理和对照之间没有显著差异[61],都无法避免骨质丢失。尽管仍然缺乏仅用钙和维生素D可以对无经期妇女有利的证据,但它们仍在广泛使用,以预防钙和维生素D的缺乏所导致的骨质丢失[62]。每日推荐量为:钙1200-1500毫克,维生素D400-800国际单位。
乙酰左旋肉碱
乙酰左旋肉碱是一种氨基酸,可能对控制女性性激素的脑部化学物质和激素有效果。在一项初步实验中,对血液中雌性激素水平或低或正常的闭经女性,给予每天2克的乙酰左旋揉肩。发现:对于之前雌性激素水平较低的女性,用药后激素水平上升;所有女性受试者中,有一半人在用药3-6个月后恢复了月经[63]。为了确认这个有意义的结果,需要进一步的对照实验。
维生素C
一项初步研究表明[64],仅管维生素C(每天400毫克)可以使一些原本月经正常但不排卵的妇女排卵,但仅使用维生素C对于闭经没有效果。在此研究的第二阶段,当采用维生素C和一种影响雌性激素水平的药物合用时,可以使半数的受试的闭经妇女恢复排卵,而单独使用此种药物没有这样的效果。为了弄清维生素C与闭经的关系,需进行更进一步的研究。
催乳激素
催乳激素是一种在某些闭经情况下升高的激素。一项针对三名有着高催乳激素水平的闭经女性的初步研究[65]发现,每天给予200-600毫克的维生素B6可以使月经周期恢复;然而即使是600毫克/每天的维生素B6也不能使非催乳激素升高型闭经妇女的月经周期恢复。一些列其它小型的初步试验[66,67,68,69,70]并没有证实口服或注射的维生素B6与体内催乳激素水平的关系,对于是否恢复月经周期,这些研究的结果也并不一致[71,72,73]。还需要更大一些的对照实验来确定维生素B6对于调理闭经的功能。
锌
尽管锌被认为对于生殖功能有着多方面的作用,但其与闭经的关系,却几乎没有研究设计[74]。在一项针对高强度练习的运动员的研究中,发现运动员有闭经与锌的缺乏无关[75]。因此需要更多的研究。
有无副作用及药物之间相互作用?
请参考各种营养补充物的副作用及相互作用。
可能有益的草药
蓝籽类叶牡丹
蓝籽类叶牡丹是对于月经缺乏的传统疗法。它被认为是一种通经剂(刺激月经血流的物质)和子宫滋补剂。还没有临床实验证实这种传统用法的科学性。
其它草药通经剂,如益母草,芸香,越桔,西洋蓍草,传统上被认为可以改善月经过少或闭经。以上所有草药都没有进行过关于对闭经疗效的现代临床实验。所有的通经剂都应该避免在怀孕期使用,因为它们可能会导致流产。
圣洁莓
在运用草药的医学中,圣洁莓(Vitex agnus-castus)(贞节树)有时被用于治疗女性不育和闭经[76]。催乳激素水平升高可能导致闭经,而圣洁莓在动物实验中被证实可以降低催乳激素水平[77]。在一项对照实验中,使用三个月的圣洁莓治疗后,原本催乳激素水平升高的女性的该激素水平变为正常[78]。研究还发现[79]:在黄体期缺陷的妇女(一种同样可能导致月经不调,包括闭经的疾病),圣洁莓可以提高黄体酮和之后孕激素的水平。到目前为止,只有一个小型的初步试验用于研究圣洁莓用于闭经的疗效。该研究发现:在持续六个月,每天一次服用40滴液体圣洁莓制剂的15名闭经的女性中,有10人恢复了正常的月经周期[80]。还需要进一步的研究来探究圣洁莓在对于闭经的调理中起到的作用。
有无副作用及药物之间相互作用?
请参考各种草药的副作用及相互作用
可能有效的整体疗法
一系列初步试验显示[81,82.83],在有排卵异常的妇女(包括无排卵)中,针灸具有促进排卵的作用。初步研究发现:针灸可以提高机体的雌激素,孕激素,以及相关的黄体生成素和卵泡刺激素水平[84,85]。几乎没有研究涉及针灸对于闭经的治疗作用,但一项初步试验表明,针灸对于月经间隔过长的妇女有效[86]。在一项对照实验中,针灸之后,闭经妇女表现出恢复正常激素水平的趋势[87]。
参考文献
1. :Fagan KM. Pharmacologic management of athletic amenorrhea. Sports Pharmacology 1998;17:327–41 [review].
2. :Yen SS. Effects of lifestyle and body composition on the ovary. Endocrinol Metab Clin North Am 1998;27:915–26,ix [review].
3. :Sanborn CF, Horea M, Siemers BJ, Dieringer KI. Disordered eating and the female athlete triad. Clin Sports Med 2000;19:199–213 [review].
4. :Berga SL, Loucks-Daniels TL, Adler LJ, et al. Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea. Am J Obstet Gynecol 2000;182:776–81.
5. :Carmichael KA, Carmichael DH. Bone metabolism and osteopenia in eating disorders. Medicine (Baltimore) 1995;74:254–67 [review].
6. :McNeilly AS, Tay CC, Glasier A. Physiological mechanisms underlying lactational amenorrhea. Ann N Y Acad Sci 1994;709:145–55 [review].
7. :Kalkwarf HJ. Hormonal and dietary regulation of changes in bone density during lactation and after weaning in women. J Mammary Gland Biol Neoplasia 1999;4:319–29 [review].
8. Bringer J, Lefebvre P, Renard E. Nutritional hypogonadism. Rev Prat 1999;49:1291–6 [review, in French].
9. Yen SS. Effects of lifestyle and body composition on the ovary. Endocrinol Metab Clin North Am 1998;27:915–26,ix [review].
10. Bringer J, Lefebvre P, Renard E. Nutritional hypogonadism. Rev Prat 1999;49:1291–6 [review, in French].
11. Dueck CA, Matt KS, Manore MM, Skinner JS. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr 1996;6:24–40.
12. Kopp-Woodroffe SA, Manore MM, Dueck CA, et al. Energy and nutrient status of amenorrheic athletes participating in a diet and exercise training intervention program. Int J Sport Nutr 1999;9:70–88.
13. Miller KK, Parulekar MS, Schoenfeld E, et al. Decreased leptin levels in normal weight women with hypothalamic amenorrhea: the effects of body composition and nutritional intake. J Clin Endocrinol Metab 1998;83:2309–12.
14. Snow RC, Schneider JL, Barbieri RL. High dietary fiber and low saturated fat intake among oligomenorrheic undergraduates. Fertil Steril 1990;54:632–7.
15. Warren MP, Holderness CC, Lesobre V, et al. Hypothalamic amenorrhea and hidden nutritional insults. J Soc Gynecol Investig 1994;1:84–8.
16. Couzinet B, Young J, Brailly S, et al. Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 1999;50:229–35.
17. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998;83:25–32.
18. Couzinet B, Young J, Brailly S, et al. Functional hypothalamic amenorrhoea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol (Oxf) 1999;50:229–35.
19. Koebnick C, Strassner C, Hoffmann I, Leitzmann C. Consequences of a long-term raw food diet on body weight and menstruation: results of a questionnaire survey. Ann Nutr Metab 1999;43:69–79.
20. Barr SI. Vegetarianism and menstrual cycle disturbances: is there an association? Am J Clin Nutr 1999;70:549S–54S [review].
21. Kemmann E, Pasquale SA, Skaf R. Amenorrhea associated with carotenemia. JAMA 1983;249:926–9.
22. Frumar AM, Meldrum DR, Judd HL. Hypercarotenemia in hypothalamic amenorrhea. Fertil Steril 1979;32:261–4.
23. Martin-Du Pan RC, Hermann W, Chardon F. Hypercarotenemia, amenorrhea and a vegetarian diet. J Gynecol Obstet Biol Reprod (Paris) 1990;19(3):290–4 [in French].
24. Kemmann E, Pasquale SA, Skaf R. Amenorrhea associated with carotenemia. JAMA 1983;249:926–9.
25. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 1995;74:587–601.
26. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333–40.
27. Lu LJ, Anderson KE, Grady JJ, et al. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res 2000;60:4112–21.
28. Wu AH, Stanczyk FZ, Hendrich S, et al. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer 2000;82:1879–86.
29. Xu X, Duncan AM, Merz BE, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:1101–8.
30. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev 1996;5:63–70.
31. Martini MC, Dancisak BB, Haggans CJ, et al. Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr Cancer 1999;34:133–9.
32. Duncan AM, Merz BE, Xu X, et al. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999;84:192–7.
33. Barr SI. Vegetarianism and menstrual cycle disturbances: is there an association? Am J Clin Nutr 1999;70:549S–54S [review].
34. Warren MP, Stiehl AL. Exercise and female adolescents: effects on the reproductive and skeletal systems. J Am Med Womens Assoc 1999;54:115–20, 138 [review].
35. Jonnavithula S, Warren MP, Fox RP, Lazaro MI. Bone density is compromised in amenorrheic women despite return of menses: a 2-year study. Obstet Gynecol 1993;81:669–74.
36. Sanborn CF, Horea M, Siemers BJ, Dieringer KI. Disordered eating and the female athlete triad. Clin Sports Med 2000;19:199–213 [review].
37. Manore MM. Nutritional needs of the female athlete. Clin Sports Med 1999;18:549–63 [review].
38. Benson JE, Engelbert-Fenton KA, Eisenman PA. Nutritional aspects of amenorrhea in the female athlete triad. Int J Sport Nutr 1996;6:134–45 [review].
39. Frederick L, Hawkins ST. A comparison of nutrition knowledge and attitudes, dietary practices, and bone densities of postmenopausal women, female college athletes, and nonathletic college women. J Am Diet Assoc 1992;92:299–305.
40. Hirschberg AL, Hagenfeldt K. Athletic amenorrhea and its consequences. Hard physical training at an early age can cause serious bone damage. Lakartidningen 1998;95:5765–70 [review, in Swedish].
41. Kleiner SM, Bazzarre TL, Ainsworth BE. Nutritional status of nationally ranked elite bodybuilders. Int J Sport Nutr 1994;4:54–69.
42. Dueck CA, Matt KS, Manore MM, Skinner JS. Treatment of athletic amenorrhea with a diet and training intervention program. Int J Sport Nutr 1996;6:24–40.
43. Kopp-Woodroffe SA, Manore MM, Dueck CA, et al. Energy and nutrient status of amenorrheic athletes participating in a diet and exercise training intervention program. Int J Sport Nutr 1999;9:70–88.
44. McNeilly AS, Tay CC, Glasier A. Physiological mechanisms underlying lactational amenorrhea. Ann NY Acad Sci 1994;709:145–55.
45. Peng YK, Hight-Laukaran V, Peterson AE, Perez-Escamilla R. Maternal nutritional status is inversely associated with lactational amenorrhea in Sub-Saharan Africa: results from demographic and health surveys II and III. J Nutr 1998;128:1672–80.
46. Delgado HL, Martorell R, Klein RE. Nutrition, lactation, and birth interval components in rural Guatemala. Am J Clin Nutr 1982;35:1468–76.
47. Lunn PG, Austin S, Prentice AM, Whitehead RG. The effect of improved nutrition on plasma prolactin concentrations and postpartum infertility in lactating Gambian women. Am J Clin Nutr 1984;39:227–35.
48. Tracer DP. Lactation, nutrition, and postpartum amenorrhea in lowland Papua New Guinea. Hum Biol 1996;68:277–92.
49. Prema K, Naidu AN, Neelakumari S, Ramalakshmi BA. Nutrition—fertility interaction in lactating women of low income groups. Br J Nutr 1981;45:461–7.
50. Heinig MJ, Nommsen-Rivers LA, Peerson JM, Dewey KG. Factors related to duration of postpartum amenorrhoea among USA women with prolonged lactation. J Biosoc Sci 1994;26:517–27.
51. Lunn PG, Prentice AM, Austin S, Whitehead RG. Influence of maternal diet on plasma-prolactin levels during lactation. Lancet 1980 Mar 22;1(8169):623–5 [review].
52. Tennekoon KH, Karunanayake EH, Seneviratne HR. Effect of skim milk supplementation of the maternal diet on lactational amenorrhea, maternal prolactin, and lactational behavior. Am J Clin Nutr 1996;64:283–90.
53. Kalkwarf HJ. Hormonal and dietary regulation of changes in bone density during lactation and after weaning in women. J Mammary Gland Biol Neoplasia 1999;4:319–29 [review].
54. Berga SL, Loucks-Daniels TL, Adler LJ, et al. Cerebrospinal fluid levels of corticotropin-releasing hormone in women with functional hypothalamic amenorrhea. Am J Obstet Gynecol 2000;182:776–81.
55. Gallinelli A, Matteo ML, Volpe A, Facchinetti F. Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea. Fertil Steril 2000;73:812–6.
56. Meczekalski B, Tonetti A, Monteleone P, et al. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test. Eur J Endocrinol 2000;142:280–5.
57. Gallinelli A, Matteo ML, Volpe A, Facchinetti F. Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea. Fertil Steril 2000;73:812–6.
58. Johnson J, Whitaker AH. Adolescent smoking, weight changes, and binge-purge behavior: associations with secondary amenorrhea. Am J Public Health 1992;82:47–54.
59. Shangold MM, Tomai TP, Cook JD, et al. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea. Fertil Steril 1991;56:1040–7.
60. Baer JT, Taper LJ, Gwazdauskas FG, et al. Diet, hormonal, and metabolic factors affecting bone mineral density in adolescent amenorrheic and eumenorrheic female runners. J Sports Med Phys Fitness 1992;32:51–8.
61. Kalkwarf HJ, Specker BL, Ho M. Effects of calcium supplementation on calcium homeostasis and bone turnover in lactating women. J Clin Endocrinol Metab 1999;84:464–70.
62. Fagan KM. Pharmacologic management of athletic amenorrhea. Clin Sports Med 1998;17:327–41 [review].
63. Genazzani AD, Petraglia F, Algeri I, et al. Acetyl-l-carnitine as possible drug in the treatment of hypothalamic amenorrhea. Acta Obstet Gynecol Scand 1991;70:487–92.
64. Igarashi M. Augmentative effect of ascorbic acid upon induction of human ovulation in clomiphene-ineffective anovulatory women. Int J Fertil 1977;22:168–73.
65. McIntosh EN. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6). J Clin Endocrinol Metab 1976;42:1192–5.
66. Kidd GS, Dimond R, Kark JA, et al. The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes. J Clin Endocrinol Metab 1982;54:872–5.
67. Spiegel AM, Rosen SW, Weintraub BD, Marynick SP. Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects. J Clin Endocrinol Metab 1978;46:686–8.
68. Lehtovirta P, Ranta T, Seppala M. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes. Acta Endocrinol (Copenh) 1978;87:682–6.
69. Tolis G, Laliberte R, Guyda H, Naftolin F. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes. J Clin Endocrinol Metab 1977;44:1197–9.
70. Goodenow TJ, Malarkey WB. Ineffectiveness of pyridoxine in evaluation and treatment of the hyperprolactinemic amenorrhea-galactorrhea syndrome. Am J Obstet Gynecol 1979;133:161–4.
71. Tolis G, Laliberte R, Guyda H, Naftolin F. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes. J Clin Endocrinol Metab 1977;44:1197–9.
72. Lehtovirta P, Ranta T, Seppala M. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes. Acta Endocrinol (Copenh) 1978;87:682–6.
73. Kidd GS, Dimond R, Kark JA, et al. The effects of pyridoxine on pituitary hormone secretion in amenorrhea-galactorrhea syndromes. J Clin Endocrinol Metab 1982;54:872–5.
74. Medal LS, Lisker R, Prasad AS. Importance of zinc in human nutrition. Am J Clin Nutr 1968;21:191–2.
75. Singh A, Deuster PA, Moser PB. Zinc and copper status in women by physical activity and menstrual status. J Sports Med Phys Fitness 1990;30:29–36.
76. Veal L. Complementary therapy and infertility: an Icelandic perspective. Complement Ther Nurs Midwifery 1998;4:3–6 [review].
77. Sliutz G, Speiser P, Schultz AM, et al. Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 1993;25:253–5.
78. Milewicz A, Gejdel E, Sworen H, et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 1993;43:752–6 [in German].
79. Brown DJ. Herbal Prescriptions for Health and Healing. Roseville, CA: Prima Health, 2000, 235–8.
80. Loch EG, Katzorke T. Diagnosis and treatment of dyshormonal menstrual periods in general practice. Gynäkol Praxis 1990;14:489–95.
81. Stener-Victorin E, Waldenstrom U, Tagnfors U, et al. Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2000;79:180–8.
82. Mo X, Li D, Pu Y, et al. Clinical studies on the mechanism for acupuncture stimulation of ovulation. J Tradit Chin Med 1993;13:115–9.
83. Yu J, Zheng HM, Ping SM. Changes in serum FSH, LH and ovarian follicular growth during electroacupuncture for induction of ovulation. Chung Hsi I Chieh Ho Tsa Chih 1989;9:199–202,195 [in Chinese].
84. Mo X, Li D, Pu Y, et al. Clinical studies on the mechanism for acupuncture stimulation of ovulation. J Tradit Chin Med 1993;13:115–9.
85. Yu J, Zheng HM, Ping SM. Changes in serum FSH, LH and ovarian follicular growth during electroacupuncture for induction of ovulation. Chung Hsi I Chieh Ho Tsa Chih 1989;9:199–202,195 [in Chinese].
86. Gerhard I, Postneek F. Possibilities of therapy by ear acupuncture in female sterility. Geburtshilfe Frauenheilkd 1988;48:165–71 [in German].
87. Kubista E, Boschitsch E, Spona J. Effect of ear-acupuncture on the LH-concentration in serum in patients with secondary amenorrhea. Wien Med Wochenschr 1981;131:123–6 [in German].
|